Furthermore, AD patients revealed lipid metabolism disorders characterized by excessive accumulation of long-chain fatty acids and elevated ceramide levels in the brain, along with diminished peroxisome count and decreased expression of PPARγ protein and mRNA. The gene discussed is PPARG; the disease is Alzheimer disease.